Side by side
Compare companies
Line up to six companies across valuation, growth, profitability, leverage, ownership and technicals. Best and worst per row are highlighted.
| Metric | MOLBIO | POLYMED | FISCHER | TARSONS | LAXMIDENTL |
|---|---|---|---|---|---|
| Size & Price | |||||
| Market capitalisation | ₹17,431 Cr | ₹16,610 Cr | ₹2,190 Cr | ₹1,752 Cr | ₹1,066 Cr |
| Enterprise value | ₹17,844 Cr | ₹16,952 Cr | ₹2,262 Cr | ₹2,135 Cr | ₹1,066 Cr |
| Revenue (TTM) | ₹1,020 Cr | ₹1,997 Cr | ₹367 Cr | ₹441 Cr | ₹287 Cr |
| EBITDA (TTM) | ₹262 Cr | ₹461 Cr | ₹50 Cr | ₹119 Cr | ₹46 Cr |
| PAT (TTM) | ₹145 Cr | ₹315 Cr | ₹30 Cr | ₹11 Cr | ₹31 Cr |
| Current price | ₹1,513.10 | ₹1,638.10 | ₹33.46 | ₹329.40 | ₹193.87 |
| 1-day change | +15.6% | -2.13% | -0.27% | +2.84% | +1.28% |
| Avg volume (30d) | — | — | — | — | — |
| 52-week high | — | — | — | — | — |
| 52-week low | — | — | — | — | — |
| Distance from 52w high | — | — | — | — | — |
| Distance from 52w low | — | — | — | — | — |
| Valuation | |||||
| Price to earnings | 120.1× | 52.7× | 73.5× | 157.9× | 34.5× |
| Price to book | 14.6× | 5.3× | 5.7× | 2.8× | 4.4× |
| Price to sales | 17.1× | 8.3× | 6.0× | 4.0× | 3.7× |
| EV / EBITDA | 68.0× | 36.7× | 45.2× | 17.9× | 23.2× |
| Dividend yield | 0% | 0.43% | 0.15% | 0.61% | 0% |
| Earnings yield | 0.83% | 1.9% | 1.36% | 0.63% | 2.9% |
| PEG ratio | — | 2.44 | — | — | — |
| Book value / share | ₹103.7 | ₹306.4 | ₹5.9 | ₹119.3 | ₹44.3 |
| EPS (TTM) | ₹12.9 | ₹31.1 | ₹0.5 | ₹2.1 | ₹5.6 |
| Growth | |||||
| Sales growth (1y) | 22% | 12.3% | 178.8% | 7.7% | 16.2% |
| Sales growth (3y CAGR) | — | 18.9% | 1,096.8% | 12% | — |
| Sales growth (5y CAGR) | — | 19% | 348.5% | — | — |
| Profit growth (1y) | 42.3% | -4.9% | 2,463.6% | -51.9% | -8.8% |
| Profit growth (3y CAGR) | — | 21.6% | — | -47.8% | — |
| Profit growth (5y CAGR) | — | 18.8% | 194.5% | — | — |
| Qtr sales growth (YoY) | — | 30.3% | 249.5% | 20.7% | 13.9% |
| Qtr profit growth (YoY) | — | -8.4% | -24.4% | -180.9% | 23.9% |
| Profitability | |||||
| Operating margin | 25.7% | 23.6% | 14% | 27.9% | 15.6% |
| Net margin | 13.6% | 17.1% | 10.1% | 3.4% | 10.4% |
| Return on equity | 16.2% | 11% | 8.6% | 2.3% | 12.8% |
| Return on capital employed | 23.7% | 14.5% | 13.6% | 5% | 14.7% |
| Return on assets | 6.5% | 8.2% | 4.6% | 1.2% | 9.8% |
| ROE (3y avg) | 9.8% | 15.3% | 3.8% | 4.9% | 32.5% |
| ROCE (3y avg) | 16.6% | 20.3% | 5.9% | 8% | 18.4% |
| Leverage & Quality | |||||
| Debt to equity | 0.35 | 0.11 | 0.19 | 0.6 | 0 |
| Interest coverage | 12.8× | 24.4× | 9.0× | 2.0× | 26.3× |
| Current ratio | 2.48 | 3.37 | 1.62 | 1.01 | 6.21 |
| Working capital days | — | 294 | 111 | 361 | 109 |
| Ownership | |||||
| Promoter holding | 41.3% | 62.4% | 62.2% | 47.3% | 41.8% |
| Promoter pledge | 0% | 0% | 0% | 0% | 0% |
| FII holding | 1.5% | 5.6% | 5.5% | 0.2% | 30.1% |
| DII holding | 16.4% | 16.1% | 1.4% | 0.1% | 10.9% |
| Public holding | 40.8% | 15.9% | 31% | 52.4% | 17.2% |
| Promoter holding change (1y) | — | -0.02% | 0.35% | -0.01% | 0.1% |
| Technical | |||||
| 50-day moving average | — | — | — | — | — |
| 200-day moving average | — | — | — | — | — |
| Price vs 50 DMA | — | — | — | — | — |
| Price vs 200 DMA | — | — | — | — | — |
| RSI (14) | — | — | — | — | — |
| Return (1m) | — | — | — | — | — |
| Return (3m) | — | — | — | — | — |
| Return (6m) | — | — | — | — | — |
| Return (1y) | — | — | — | — | — |
| Return (3y CAGR) | — | — | — | — | — |
| Relative strength (1y) | — | — | — | — | — |
| Volatility (1y) | — | — | — | — | — |
| Beta | — | — | — | — | — |
best in row weakest in rowRows without a better/worse direction aren't highlighted.